NVDA Financial Statements & Analysis
Complete financial statements for NVDA including income statement, balance sheet, and cash flow statement. Analyze NVDA's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
76
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
114.2% ↑
Net Income
144.9% ↑
Gross Margin
3.1% ↑
Operating Margin
15.3% ↑
Balance Sheet
Current Ratio
6.4% ↑
Debt to Equity
-49.7% ↑
Asset Turnover
26.2% ↑
Cash Flow
Operating Cash Flow
128.2% ↑
Net Cash Flow
-66.4% ↓
Free Cash Flow
125.2% ↑
Cash Flow to Debt
145.6% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 60.92B | 130.50B | 114.2% | |
| Gross Profit | 44.30B | 97.86B | 120.9% | |
| Operating Income | 32.97B | 81.45B | 147.0% | |
| Net Income | 29.76B | 72.88B | 144.9% | |
| EPS | 1.21 | 2.97 | 145.5% | |
| EBITDA | 35.58B | 86.14B | 142.1% | |
| Gross Margin | 72.72% | 74.99% | 3.1% | |
| Operating Margin | 54.12% | 62.42% | 15.3% | |
| Net Income Margin | 48.85% | 55.85% | 14.3% | |
| R&D Expenses | 8.68B | 12.91B | 48.9% |
Income Statement Full Table
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 130.50B | 60.92B | 26.97B | 26.91B | 16.68B |
| Gross Profit | 97.86B | 44.30B | 15.36B | 17.48B | 10.40B |
| Operating Income | 81.45B | 32.97B | 4.22B | 10.04B | 4.53B |
| Net Income | 72.88B | 29.76B | 4.37B | 9.75B | 4.33B |
| EPS | 2.97 | 1.21 | 0.18 | 0.39 | 0.18 |
| EBITDA | 86.14B | 35.58B | 5.99B | 11.35B | 5.69B |
| Gross Margin | 74.99% | 72.72% | 56.93% | 64.93% | 62.34% |
| Operating Margin | 62.42% | 54.12% | 15.66% | 37.31% | 27.18% |
| Net Income Margin | 55.85% | 48.85% | 16.19% | 36.23% | 25.98% |
| R&D Expenses | 12.91B | 8.68B | 7.34B | 5.27B | 3.92B |